Saudi Pharmaceutical Industries and Medical Appliances Corp (SPIMACO) reported a net profit of SAR 161.6 million in the first nine months of 2017, a rise of 19.3 percent year-on-year (YoY). The profit growth was attributed to lower selling and marketing expenses and gains from sale of securities investments.
| Item | 9m 2016 | 9m 2017 | Change |
|---|---|---|---|
| Revenues | 918.96 | 975.35 | 6.1 % |
| Gross Income | 518.38 | 497.39 | (4.0 %) |
| Operating Income | 89.87 | 107.74 | 19.9 % |
| Net Income | 133.28 | 130.75 | (1.9 %) |
| Average Shares | 120.00 | 120.00 | - |
| EPS (Riyals) | 1.11 | 1.09 | (1.9 %) |
The third quarter net profit increased by 9 percent YoY to SAR 8.2 million, backed by SAR 4 million in profit share from affiliates.
When compared to Q2 2017, the pharmaceutical producer’s net income slumped 85 percent, impacted by drops in operating revenue and gross profit, along with an increase in other operating expenses.
| Item | Q3 2016 | Q3 2017 | Change |
|---|---|---|---|
| Revenues | 257.21 | 277.62 | 7.9 % |
| Gross Income | 140.54 | 128.68 | (8.4 %) |
| Operating Income | 9.14 | 8.30 | (9.2 %) |
| Net Income | 4.76 | (17.03) | (457.9 %) |
| Average Shares | 120.00 | 120.00 | - |
| EPS (Riyals) | 0.04 | (0.14) | (457.9 %) |
| Item | Q2 2017 | Q3 2017 | Change |
|---|---|---|---|
| Revenues | 304.63 | 277.62 | (8.9 %) |
| Gross Income | 156.13 | 128.68 | (17.6 %) |
| Operating Income | 49.40 | 8.30 | (83.2 %) |
| Net Income | 46.56 | (17.03) | (136.6 %) |
| Average Shares | 120.00 | 120.00 | - |
| EPS (Riyals) | 0.39 | (0.14) | (136.6 %) |
| Period | Revenues | Change | Gross Income | Change | Net Income | Change | EPS(Riyal) |
|---|---|---|---|---|---|---|---|
| Q1 2008 | 220.58 | 8.5 % | 99.57 | 9.4 % | 40.93 | 3.6 % | 0.40 |
| Q2 2008 | 211.66 | 1.1 % | 74.78 | 12.5 % | 34.24 | 51.7 % | 0.34 |
| Q3 2008 | 145.45 | (2.6 %) | 74.34 | 11.2 % | 15.62 | (41.1 %) | 0.15 |
| Q4 2008 | 294.26 | 24.8 % | 114.28 | 11.7 % | 37.48 | 12.6 % | 0.37 |
| 2008 | 871.94 | 9.3 % | 362.97 | 11.1 % | 128.27 | 5.2 % | 1.26 |
| Q1 2009 | 257.88 | 16.9 % | 108.57 | 9.0 % | 42.69 | 4.3 % | 0.42 |
| Q2 2009 | 229.00 | 8.2 % | 81.53 | 9.0 % | 37.81 | 10.4 % | 0.37 |
| Q3 2009 | 171.15 | 17.7 % | 72.49 | (2.5 %) | 15.84 | 1.4 % | 0.16 |
| Q4 2009 | 292.71 | (0.5 %) | 157.00 | 37.4 % | 58.48 | 56.0 % | 0.58 |
| 2009 | 950.74 | 9.0 % | 419.59 | 15.6 % | 154.81 | 20.7 % | 1.53 |
| Q1 2010 | 274.33 | 6.4 % | 118.90 | 9.5 % | 45.32 | 6.2 % | 0.38 |
| Q2 2010 | 252.34 | 10.2 % | 100.50 | 23.3 % | 43.09 | 14.0 % | 0.36 |
| Q3 2010 | 191.40 | 11.8 % | 85.88 | 18.5 % | 18.07 | 14.1 % | 0.15 |
| Q4 2010 | 319.57 | 9.2 % | 181.12 | 15.4 % | 70.04 | 19.8 % | 0.58 |
| 2010 | 1,037.64 | 9.1 % | 486.40 | 15.9 % | 176.52 | 14.0 % | 1.47 |
| Q1 2011 | 252.08 | (8.1 %) | 123.51 | 3.9 % | 45.71 | 0.9 % | 0.38 |
| Q2 2011 | 292.08 | 15.7 % | 123.61 | 23.0 % | 60.75 | 41.0 % | 0.51 |
| Q3 2011 | 209.24 | 9.3 % | 106.76 | 24.3 % | 29.75 | 64.6 % | 0.25 |
| Q4 2011 | 375.82 | 17.6 % | 206.69 | 14.1 % | 74.06 | 5.7 % | 0.62 |
| 2011 | 1,129.22 | 8.8 % | 560.57 | 15.2 % | 211.44 | 19.8 % | 1.76 |
| Q1 2012 | 303.14 | 20.3 % | 153.21 | 24.0 % | 56.45 | 23.5 % | 0.47 |
| Q2 2012 | 286.64 | (1.9 %) | 140.91 | 14.0 % | 90.14 | 48.4 % | 0.75 |
| Q3 2012 | 227.40 | 8.7 % | 113.28 | 6.1 % | 32.33 | 8.7 % | 0.27 |
| Q4 2012 | 365.97 | (2.6 %) | 211.16 | 2.2 % | 53.73 | (27.5 %) | 0.45 |
| 2012 | 1,183.15 | 4.8 % | 618.56 | 10.3 % | 232.65 | 10.0 % | 1.94 |
| Q1 2013 | 361.37 | 19.2 % | 184.62 | 20.5 % | 63.15 | 11.9 % | 0.53 |
| Q2 2013 | 344.22 | 20.1 % | 179.12 | 27.1 % | 113.71 | 26.1 % | 0.95 |
| Q3 2013 | 222.91 | (2.0 %) | 118.64 | 4.7 % | 34.19 | 5.8 % | 0.28 |
| Q4 2013 | 382.01 | 4.4 % | 226.14 | 7.1 % | 57.01 | 6.1 % | 0.48 |
| 2013 | 1,310.50 | 10.8 % | 708.52 | 14.5 % | 266.82 | 14.7 % | 2.22 |
| Q1 2014 | 405.21 | 12.1 % | 206.72 | 12.0 % | 91.17 | 44.4 % | 0.76 |
| Q2 2014 | 371.14 | 7.8 % | 193.14 | 7.8 % | 97.72 | (14.1 %) | 0.81 |
| Q3 2014 | 266.02 | 19.3 % | 134.45 | 13.3 % | 36.69 | 7.3 % | 0.31 |
| Q4 2014 | 431.06 | 12.8 % | 261.80 | 15.8 % | 91.29 | 60.1 % | 0.76 |
| 2014 | 1,470.19 | 12.2 % | 794.54 | 12.1 % | 316.85 | 18.8 % | 2.64 |
| Q1 2015 | 432.20 | 6.7 % | 225.86 | 9.3 % | 99.39 | 9.0 % | 0.83 |
| Q2 2015 | 435.80 | 17.4 % | 210.95 | 9.2 % | 237.63 | 143.2 % | 1.98 |
| Q3 2015 | 308.27 | 15.9 % | 131.32 | (2.3 %) | 29.16 | (20.5 %) | 0.24 |
| Q4 2015 | 520.38 | 20.7 % | 266.38 | 1.7 % | (9.12) | (110.0 %) | (0.08) |
| 2015 | 1,705.05 | 16.0 % | 848.60 | 6.8 % | 357.05 | 12.7 % | 2.98 |
| Q1 2016 | 322.20 | (25.4 %) | 194.26 | (14.0 %) | 88.91 | (10.5 %) | 0.74 |
| Q2 2016 | 339.54 | (22.1 %) | 183.58 | (13.0 %) | 39.61 | (83.3 %) | 0.33 |
| Q3 2016 | 257.21 | (16.6 %) | 140.54 | 7.0 % | 4.76 | (83.7 %) | 0.04 |
| Q4 2016 | 339.59 | (34.7 %) | 194.16 | (27.1 %) | 143.48 | 1673.8 % | 1.20 |
| 2016 | 1,258.55 | (26.2 %) | 712.54 | (16.0 %) | 276.76 | (22.5 %) | 2.31 |
| Q1 2017 | 393.10 | 22.0 % | 212.58 | 9.4 % | 101.22 | 13.8 % | 0.84 |
| Q2 2017 | 304.63 | (10.3 %) | 156.13 | (15.0 %) | 46.56 | 17.5 % | 0.39 |
| Q3 2017 | 277.62 | 7.9 % | 128.68 | (8.4 %) | (17.03) | (457.9 %) | (0.14) |
| Period | Revenues | Change | Gross Income | Change | Net Income | Change | EPS(Riyal) |
|---|---|---|---|---|---|---|---|
| 2007 | 797.75 | 9.6 % | 326.62 | 5.9 % | 121.87 | 16.0 % | 1.20 |
| 2008 | 871.94 | 9.3 % | 362.97 | 11.1 % | 128.27 | 5.2 % | 1.26 |
| 2009 | 950.74 | 9.0 % | 419.59 | 15.6 % | 154.81 | 20.7 % | 1.53 |
| 2010 | 1,037.64 | 9.1 % | 486.40 | 15.9 % | 176.52 | 14.0 % | 1.47 |
| 2011 | 1,129.22 | 8.8 % | 560.57 | 15.2 % | 211.44 | 19.8 % | 1.76 |
| 2012 | 1,183.15 | 4.8 % | 618.56 | 10.3 % | 232.65 | 10.0 % | 1.94 |
| 2013 | 1,310.50 | 10.8 % | 708.52 | 14.5 % | 266.82 | 14.7 % | 2.22 |
| 2014 | 1,470.19 | 12.2 % | 794.54 | 12.1 % | 316.85 | 18.8 % | 2.64 |
| 2015 | 1,705.05 | 16.0 % | 848.60 | 6.8 % | 357.05 | 12.7 % | 2.98 |
| 2016 | 1,258.55 | (26.2 %) | 712.54 | (16.0 %) | 276.76 | (22.5 %) | 2.31 |
| Period | Gross Margin | OIBDA Margin | Net Margin Before Unusual Items |
|---|---|---|---|
| Q1 2008 | 41.13 % | 15.70 % | 15.13 % |
| Q2 2008 | 42.03 % | 16.67 % | 16.57 % |
| Q3 2008 | 43.15 % | 16.47 % | 15.83 % |
| Q4 2008 | 41.63 % | 16.30 % | 15.25 % |
| 2008 | 41.63 % | 16.30 % | 15.16 % |
| Q1 2009 | 40.91 % | 16.13 % | 14.83 % |
| Q2 2009 | 40.87 % | 16.44 % | 14.89 % |
| Q3 2009 | 39.57 % | 15.73 % | 14.07 % |
| Q4 2009 | 44.13 % | 18.49 % | 16.63 % |
| 2009 | 44.13 % | 18.49 % | 16.63 % |
| Q1 2010 | 44.45 % | 18.88 % | 16.94 % |
| Q2 2010 | 45.32 % | 18.93 % | 17.07 % |
| Q3 2010 | 45.73 % | 18.73 % | 16.95 % |
| Q4 2010 | 46.88 % | 18.85 % | 17.32 % |
| 2010 | 46.88 % | 18.85 % | 17.32 % |
| Q1 2011 | 48.36 % | 18.99 % | 17.42 % |
| Q2 2011 | 48.73 % | 19.12 % | 18.44 % |
| Q3 2011 | 49.86 % | 19.99 % | 19.22 % |
| Q4 2011 | 49.64 % | 19.57 % | 18.62 % |
| 2011 | 49.64 % | 19.65 % | 18.72 % |
| Q1 2012 | 50.01 % | 19.86 % | 18.73 % |
| Q2 2012 | 51.72 % | 20.36 % | 21.31 % |
| Q3 2012 | 51.47 % | 20.54 % | 21.21 % |
| Q4 2012 | 52.28 % | 19.56 % | 19.66 % |
| 2012 | 52.28 % | 19.56 % | 19.66 % |
| Q1 2013 | 52.36 % | 19.26 % | 19.28 % |
| Q2 2013 | 52.98 % | 18.87 % | 20.24 % |
| Q3 2013 | 53.58 % | 18.66 % | 20.45 % |
| Q4 2013 | 54.06 % | 18.26 % | 20.45 % |
| 2013 | 54.06 % | 18.16 % | 20.36 % |
| Q1 2014 | 53.95 % | 17.92 % | 21.86 % |
| Q2 2014 | 53.91 % | 17.74 % | 20.28 % |
| Q3 2014 | 53.39 % | 16.79 % | 19.84 % |
| Q4 2014 | 54.03 % | 18.15 % | 21.50 % |
| 2014 | 54.04 % | 18.15 % | 21.55 % |
| Q1 2015 | 54.34 % | 18.90 % | 21.67 % |
| Q2 2015 | 53.23 % | 18.31 % | 20.04 % |
| Q3 2015 | 51.63 % | 17.40 % | 19.05 % |
| Q4 2015 | 49.19 % | 17.17 % | 19.11 % |
| 2015 | 49.77 % | 16.85 % | 19.02 % |
| Q1 2016 | 50.60 % | 15.90 % | 18.80 % |
| Q2 2016 | 52.04 % | 15.52 % | 16.88 % |
| Q3 2016 | 54.52 % | 15.09 % | 15.79 % |
| Q4 2016 | 56.62 % | 10.25 % | 5.68 % |
| 2016 | 56.62 % | 10.25 % | 5.68 % |
| Q1 2017 | 54.97 % | 9.67 % | 3.99 % |
| Q2 2017 | 54.34 % | 11.85 % | 4.64 % |
| Q3 2017 | 52.59 % | 11.94 % | 2.91 % |
| Period | Gross Margin | OIBDA Margin | Net Margin Before Unusual Items |
|---|---|---|---|
| 2007 | 40.94 % | 15.79 % | 15.28 % |
| 2008 | 41.63 % | 16.30 % | 15.16 % |
| 2009 | 44.13 % | 18.49 % | 16.63 % |
| 2010 | 46.88 % | 18.85 % | 17.32 % |
| 2011 | 49.64 % | 19.65 % | 18.72 % |
| 2012 | 52.28 % | 19.56 % | 19.66 % |
| 2013 | 54.06 % | 18.16 % | 20.36 % |
| 2014 | 54.04 % | 18.15 % | 21.55 % |
| 2015 | 49.77 % | 16.85 % | 19.02 % |
| 2016 | 56.62 % | 10.25 % | 5.68 % |
| Period | Gross Margin | OIBDA Margin | Net Margin Before Unusual Items |
|---|---|---|---|
| Q1 2008 | 45.14 % | 22.16 % | 18.55 % |
| Q2 2008 | 35.33 % | 8.71 % | 16.39 % |
| Q3 2008 | 51.11 % | 19.82 % | 13.64 % |
| Q4 2008 | 38.84 % | 15.63 % | 12.74 % |
| Q1 2009 | 42.10 % | 20.70 % | 16.62 % |
| Q2 2009 | 35.60 % | 10.54 % | 16.51 % |
| Q3 2009 | 42.35 % | 15.37 % | 9.25 % |
| Q4 2009 | 53.64 % | 24.60 % | 21.04 % |
| Q1 2010 | 43.34 % | 21.92 % | 17.70 % |
| Q2 2010 | 39.83 % | 11.52 % | 17.08 % |
| Q3 2010 | 44.87 % | 14.68 % | 9.44 % |
| Q4 2010 | 56.68 % | 24.50 % | 21.92 % |
| Q1 2011 | 49.00 % | 22.74 % | 18.13 % |
| Q2 2011 | 42.32 % | 13.00 % | 20.80 % |
| Q3 2011 | 51.02 % | 19.57 % | 14.22 % |
| Q4 2011 | 55.00 % | 22.56 % | 19.71 % |
| Q1 2012 | 50.54 % | 23.32 % | 18.62 % |
| Q2 2012 | 49.16 % | 14.95 % | 31.45 % |
| Q3 2012 | 49.82 % | 20.53 % | 14.22 % |
| Q4 2012 | 57.70 % | 19.47 % | 14.68 % |
| Q1 2013 | 51.09 % | 21.68 % | 17.48 % |
| Q2 2013 | 52.04 % | 14.20 % | 33.03 % |
| Q3 2013 | 53.22 % | 19.34 % | 15.34 % |
| Q4 2013 | 59.20 % | 18.05 % | 14.92 % |
| Q1 2014 | 51.02 % | 20.19 % | 22.50 % |
| Q2 2014 | 52.04 % | 13.80 % | 26.33 % |
| Q3 2014 | 50.54 % | 13.97 % | 13.79 % |
| Q4 2014 | 60.73 % | 22.54 % | 21.18 % |
| Q1 2015 | 52.26 % | 22.70 % | 23.00 % |
| Q2 2015 | 48.40 % | 12.42 % | 19.81 % |
| Q3 2015 | 42.60 % | 9.85 % | 9.46 % |
| Q4 2015 | 51.19 % | 20.88 % | 21.02 % |
| Q1 2016 | 60.29 % | 18.36 % | 22.80 % |
| Q2 2016 | 54.07 % | 9.77 % | 11.67 % |
| Q3 2016 | 54.64 % | 6.30 % | 1.85 % |
| Q4 2016 | 57.18 % | 6.04 % | (13.65 %) |
| Q1 2017 | 54.08 % | 14.94 % | 14.01 % |
| Q2 2017 | 51.25 % | 19.02 % | 15.29 % |
| Q3 2017 | 46.35 % | 7.17 % | (6.13 %) |
| Period | Shares Outstanding (M) | EPS (Riyal) | Adjusted EPS (Riyal) | Book Value (BV) |
|---|---|---|---|---|
| Q1 2008 | 101.51 | 1.21 | 1.21 | 26.83 |
| Q2 2008 | 101.51 | 1.33 | 1.33 | 27.74 |
| Q3 2008 | 101.51 | 1.22 | 1.27 | 21.88 |
| Q4 2008 | 101.51 | 1.26 | 1.31 | 13.76 |
| Q1 2009 | 101.51 | 1.28 | 1.33 | 14.17 |
| Q2 2009 | 101.51 | 1.32 | 1.36 | 17.62 |
| Q3 2009 | 101.51 | 1.32 | 1.32 | 19.72 |
| Q4 2009 | 101.51 | 1.53 | 1.56 | 21.46 |
| Q1 2010 | 120.00 | 1.31 | 1.36 | 22.04 |
| Q2 2010 | 120.00 | 1.36 | 1.41 | 19.98 |
| Q3 2010 | 120.00 | 1.37 | 1.43 | 21.69 |
| Q4 2010 | 120.00 | 1.47 | 1.50 | 24.48 |
| Q1 2011 | 120.00 | 1.47 | 1.47 | 25.41 |
| Q2 2011 | 120.00 | 1.62 | 1.62 | 27.29 |
| Q3 2011 | 120.00 | 1.72 | 1.72 | 25.92 |
| Q4 2011 | 120.00 | 1.75 | 1.75 | 26.50 |
| Q1 2012 | 120.00 | 1.84 | 1.84 | 30.26 |
| Q2 2012 | 120.00 | 2.09 | 2.09 | 25.75 |
| Q3 2012 | 120.00 | 2.11 | 2.11 | 26.24 |
| Q4 2012 | 120.00 | 1.94 | 1.94 | 25.28 |
| Q1 2013 | 120.00 | 1.99 | 1.99 | 27.18 |
| Q2 2013 | 120.00 | 2.19 | 2.19 | 26.14 |
| Q3 2013 | 120.00 | 2.21 | 2.21 | 27.35 |
| Q4 2013 | 120.00 | 2.23 | 2.23 | 32.18 |
| Q1 2014 | 120.00 | 2.47 | 2.47 | 32.96 |
| Q2 2014 | 120.00 | 2.33 | 2.33 | 33.21 |
| Q3 2014 | 120.00 | 2.35 | 2.35 | 35.74 |
| Q4 2014 | 120.00 | 2.64 | 2.64 | 28.75 |
| Q1 2015 | 120.00 | 2.71 | 2.71 | 27.84 |
| Q2 2015 | 120.00 | 3.87 | 2.61 | 28.72 |
| Q3 2015 | 120.00 | 3.81 | 2.55 | 24.87 |
| Q4 2015 | 120.00 | 2.98 | 2.70 | 22.17 |
| Q1 2016 | 120.00 | 2.89 | 2.49 | 20.84 |
| Q2 2016 | 120.00 | 1.24 | 2.10 | 20.49 |
| Q3 2016 | 120.00 | 1.03 | 1.89 | 20.40 |
| Q4 2016 | 120.00 | 2.31 | 0.60 | 22.59 |
| Q1 2017 | 120.00 | 2.41 | 0.44 | 23.27 |
| Q2 2017 | 120.00 | 2.47 | 0.50 | 21.52 |
| Q3 2017 | 120.00 | 2.29 | 0.32 | 22.01 |
| Period | Shares Outstanding (M) | EPS (Riyal) | Adjusted EPS (Riyal) | Book Value (BV) |
|---|---|---|---|---|
| 2007 | 101.51 | 1.20 | 1.20 | 28.41 |
| 2008 | 101.51 | 1.26 | 1.30 | 13.76 |
| 2009 | 101.51 | 1.53 | 1.56 | 21.46 |
| 2010 | 120.00 | 1.47 | 1.50 | 24.48 |
| 2011 | 120.00 | 1.76 | 1.76 | 26.50 |
| 2012 | 120.00 | 1.94 | 1.94 | 25.28 |
| 2013 | 120.00 | 2.22 | 2.22 | 32.18 |
| 2014 | 120.00 | 2.64 | 2.64 | 28.75 |
| 2015 | 120.00 | 2.98 | 2.70 | 22.17 |
| 2016 | 120.00 | 2.31 | 0.60 | 22.59 |
| Period | P/E | Adjusted P/E | Price/book |
|---|---|---|---|
| Q1 2008 | 27.68 | 27.68 | 1.25 |
| Q2 2008 | 26.79 | 26.70 | 1.28 |
| Q3 2008 | 20.49 | 19.74 | 1.14 |
| Q4 2008 | 12.99 | 12.53 | 1.19 |
| Q1 2009 | 14.92 | 14.39 | 1.35 |
| Q2 2009 | 17.20 | 16.65 | 1.28 |
| Q3 2009 | 18.29 | 18.26 | 1.22 |
| Q4 2009 | 15.25 | 14.94 | 1.08 |
| Q1 2010 | 16.69 | 16.04 | 0.99 |
| Q2 2010 | 14.70 | 14.15 | 1.00 |
| Q3 2010 | 14.64 | 14.10 | 0.93 |
| Q4 2010 | 15.82 | 15.53 | 0.95 |
| Q1 2011 | 17.65 | 17.65 | 1.02 |
| Q2 2011 | 15.68 | 15.68 | 0.93 |
| Q3 2011 | 14.41 | 14.41 | 0.96 |
| Q4 2011 | 15.03 | 15.03 | 0.99 |
| Q1 2012 | 17.92 | 17.92 | 1.09 |
| Q2 2012 | 12.56 | 12.56 | 1.02 |
| Q3 2012 | 13.70 | 13.70 | 1.10 |
| Q4 2012 | 14.74 | 14.74 | 1.13 |
| Q1 2013 | 13.60 | 13.60 | 1.00 |
| Q2 2013 | 15.51 | 15.51 | 1.30 |
| Q3 2013 | 15.70 | 15.70 | 1.27 |
| Q4 2013 | 19.02 | 19.02 | 1.32 |
| Q1 2014 | 19.07 | 19.07 | 1.43 |
| Q2 2014 | 19.29 | 19.29 | 1.36 |
| Q3 2014 | 21.41 | 21.41 | 1.41 |
| Q4 2014 | 12.89 | 12.89 | 1.18 |
| Q1 2015 | 14.78 | 14.78 | 1.44 |
| Q2 2015 | 11.59 | 17.18 | 1.56 |
| Q3 2015 | 9.46 | 14.14 | 1.45 |
| Q4 2015 | 11.16 | 12.29 | 1.50 |
| Q1 2016 | 11.15 | 12.96 | 1.55 |
| Q2 2016 | 29.96 | 17.69 | 1.81 |
| Q3 2016 | 30.18 | 16.49 | 1.53 |
| Q4 2016 | 17.72 | More than 50 | 1.81 |
| Q1 2017 | 15.03 | More than 50 | 1.56 |
| Q2 2017 | 14.32 | More than 50 | 1.64 |
| Q3 2017 | 14.43 | More than 50 | 1.50 |
| Period | P/E | Adjusted P/E | Price/book |
|---|---|---|---|
| 2007 | 33.83 | 33.83 | 1.43 |
| 2008 | 12.99 | 12.60 | 1.19 |
| 2009 | 15.25 | 14.94 | 1.08 |
| 2010 | 15.82 | 15.53 | 0.95 |
| 2011 | 14.95 | 14.95 | 0.99 |
| 2012 | 14.74 | 14.74 | 1.13 |
| 2013 | 19.11 | 19.11 | 1.32 |
| 2014 | 12.89 | 12.89 | 1.18 |
| 2015 | 11.16 | 12.29 | 1.50 |
| 2016 | 17.72 | More than 50 | 1.81 |
Q3 2017
2017
| Period | Medical & Pharmaceutical production segment | Investment activity | Eliminations |
|---|---|---|---|
| Q1 2008 | 220.58 | - | - |
| Q2 2008 | 211.66 | - | - |
| Q3 2008 | 145.45 | - | - |
| Q4 2008 | 294.25 | - | - |
| Q1 2009 | 257.88 | - | - |
| Q2 2009 | 229.00 | - | - |
| Q3 2009 | 171.15 | - | - |
| Q4 2009 | 292.71 | - | - |
| Q1 2010 | 274.33 | - | - |
| Q2 2010 | 252.34 | - | - |
| Q3 2010 | 191.41 | - | - |
| Q4 2010 | 319.57 | - | - |
| Q1 2011 | 252.08 | - | - |
| Q2 2011 | 292.08 | - | - |
| Q3 2011 | 209.24 | - | - |
| Q4 2011 | 375.82 | - | - |
| Q1 2012 | 303.14 | - | - |
| Q2 2012 | 286.65 | - | - |
| Q3 2012 | 227.40 | - | - |
| Q4 2012 | 365.97 | - | - |
| Q1 2013 | 361.37 | - | - |
| Q2 2013 | 344.22 | - | - |
| Q3 2013 | 222.91 | - | - |
| Q4 2013 | 382.01 | - | - |
| Q1 2014 | 405.21 | - | - |
| Q2 2014 | 374.14 | - | - |
| Q3 2014 | 266.02 | - | - |
| Q4 2014 | 427.82 | - | - |
| Q1 2015 | 432.29 | 14.84 | - |
| Q2 2015 | 436.99 | 195.93 | - |
| Q3 2015 | 308.38 | 9.55 | - |
| Q4 2015 | 529.24 | - | - |
| Q1 2016 | 513.97 | 25.27 | - |
| Q2 2016 | 494.92 | 9.41 | - |
| Q3 2016 | 100.39 | 6.23 | - |
| Q4 2016 | 401.35 | 247.84 | - |
| Q1 2017 | 446.00 | 50.90 | (51.45) |
| Q2 2017 | 350.01 | 1.39 | (43.30) |
| Q3 2017 | 317.29 | 4.01 | (36.78) |
| Period | Medical & Pharmaceutical production segment | Investment activity | Eliminations |
|---|---|---|---|
| 2007 | 797.75 | - | - |
| 2008 | 871.94 | - | - |
| 2009 | 950.74 | - | - |
| 2010 | 1,037.64 | - | - |
| 2011 | 1,129.22 | - | - |
| 2012 | 1,183.15 | - | - |
| 2013 | 1,310.50 | - | - |
| 2014 | 1,470.19 | - | - |
| 2015 | 1,706.80 | 115.14 | - |
| 2016 | 1,510.63 | 288.74 | (244.41) |
| Current | |
| Market Cap (M Riyal) | 4,140.00 |
| Enterprise Value (EV) (M) | 5,154.21 |
| Shares Outstanding ((M)) | 120.00 |
| EPS ( Riyal) (TTM) | (0.27) |
| Book Value (BV) ( Riyal) | 12.89 |
| Par Value ( Riyal) | 10.00 |
| Adjusted P/E (Last12) | Neg |
| P/E (TTM) | NEG |
| Price/book | 2.68 |
| Return on Average Assets (%) (TTM) | (0.79 ) |
| Return on Average Equity (%) (TTM) | (2.07 ) |
Argaam Investment Company has updated the Privacy Policy of its services and digital platforms. Know more about our Privacy Policy here.
Argaam uses cookies to personalize content, to provide social media features and analyze traffic, that we might also share with third parties. You consent to our cookies if you use this website
Comments {{getCommentCount()}}
Be the first to comment
رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}
{{comment.DisplayName}}
{{comment.ElapsedTime}}